<DOC>
	<DOCNO>NCT02387112</DOCNO>
	<brief_summary>The aim study ass whether , patient list cardiac transplantation transplantable ( T ) status , early implantation leave ventricular assist device superior current therapeutic strategy medical heart failure therapy assist device implantation serious deterioration patient 's condition .</brief_summary>
	<brief_title>Early Versus Emergency Left Ventricular Assist Device Implantation Patients Awaiting Cardiac Transplantation</brief_title>
	<detailed_description>Heart transplantation consider gold-standard therapy end-stage systolic heart failure shortage donor hearts Germany country lead widespread use leave ventricular assist device ( LVAD ) . Even transplant list , patient ' condition often deteriorate due worsen heart failure need LVAD bridge transplantation . The high mortality ( one five patient wait list dy within 1 year ) reflect severity disease . In comparison , technical progress reduce complication rate see assist device , accord recent data , mortality LVAD support low . Patient status prior LVAD implantation strong indicator postoperative outcome , i.e . patient bad condition likely develop complication . Thus , comparison standard indication early LVAD implantation ( T-status ) appear timely clinically necessary . The paucity donor heart necessitates prospective evaluation alternative treatment regimen . The aim study ass whether , patient end-stage heart failure await cardiac transplantation , strategy involve early LVAD implantation superior strategy conservative medical heart failure therapy assist device implantation severe deterioration heart failure . The investigator expect gain insight trail-blazing future treatment patient heart failure transplantation wait list , include aspect medical care . If study hypothesis confirm , treatment seriously ill patient could , one hand , optimize . On hand , positive economic effect highly probable . The result form basis future guideline treatment group patient . Thus study also make contribution solving problem ever increase number patient wait list oppose decrease willingness donate organ transplantation .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<criteria>Inclusion Criteria Patient ( male female ) eligible heart transplantation accept T Status ( transplantable ) wait list Age 18 60 year Signed informed consent &gt; 30 % 1year mortality Seattle Heart Failure Model ( SHFM ) least three follow criterion ( ) ( f ) : 1. cardiac index ( CI ) &lt; 2.5 l/min/m² 2. pulmonary capillary wedge pressure &gt; 15 mmHg 3. maximal oxygen uptake ( VO2max ) ≤10.0 ml/kg/min ≤12.0 ml/kg/min patient intolerant ßblocker 4. ratio minute ventilation ( VE ) carbon dioxide ( VCO2 ) production ( VE/VCO2 ) slope &gt; 35 5. least two hospitalization heart failure within previous 12 month 6. documented increase brain natriuretic peptide ( BNP ) NTproBNP level despite optimal medical therapy Exclusion Criteria Patient age Patient old 60 year Patient unable give consent Contraindications assist device implantation ( e.g . mechanical aortic valve , aortic insufficiency ) Contraindications anticoagulation Expected need right ventricular assist device/biventricular support expect ( e.g . due tricuspid valve insufficiency grade 3+ , right ventricular ratio short/long axis ≥0.6 , ratio right left ventricular enddiastolic diameter ( RVEDD/LVEDD ) &gt; 0.72 , restrictive cardiomyopathy ) Presence catecholamine support intraaortic balloon counterpulsation ( IABP ) Overt infection Fixed pulmonary hypertension ( i.e . pulmonary arterial pressure ( PAP ) &gt; 60 mmHg mean transpulmonary gradient ( TPG ) &gt; 15 mmHg pulmonary vascular resistance ( PVR ) &gt; 6 Wood unit despite optimal medical treatment ) Renal insufficiency ( glomerular filtration rate ( GFR ) &lt; 30ml/min need hemodialysis hemofiltration ) Significant coagulopathies Systemic lupus erythematosus , sarcoid , amyloidosis multisystem involvement still active Drug abuse and/or alcohol abuse Incompliance Elevated panel reactivity level &gt; 50 % Pregnancy breast feed woman Informed consent give detailed information receive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>End stage heart disease</keyword>
	<keyword>Ventricular assist device</keyword>
</DOC>